{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:07:39Z","timestamp":1760299659275},"reference-count":10,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0532","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:54:30Z","timestamp":1501635270000},"page":"141-147","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure"],"prefix":"10.1253","volume":"82","author":[{"given":"Shin-ichi","family":"Momomura","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yasumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amagasaki Chuo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Daimon","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Dohi","sequence":"additional","affiliation":[{"name":"Research and Development Department, Toa Eiyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsuoka H, Kuwajima I, Shimada K, Mitamura H, Saruta T. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: Randomized, double-blind, placebo-controlled study. <i>J Clin Hypertens (Greenwich)<\/i> 2013; 15: 806\u2013814.","DOI":"10.1111\/jch.12208"},{"key":"2","unstructured":"2. Matsuoka H, Kuwajima I, Shimada K, Mitamura H, Saruta T. A placebo-controlled, randomized, double-blind, dose-finding study of 2 mg, 4 mg and 8 mg bisoprolol transdermal patches (TY-0201) in Japanese patients with grade I-II essential hypertension. <i>Prog Med<\/i> 2013; 33: 2413\u20132420."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J Am Soc Echocardiogr<\/i> 2015; 28: 1\u201339.","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. <i>Am Heart J<\/i> 1992; 124: 1017\u20131025.","DOI":"10.1016\/0002-8703(92)90986-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Guyatt GH. Measurement of health-related quality of life in heart failure. <i>J Am Coll Cardiol<\/i> 1993; 22(Suppl A): 185A\u2013191A.","DOI":"10.1016\/0735-1097(93)90488-M"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Momomura S, Tsutsui H, Sugawara Y, Ito M, Mitsuhashi T, Fukamizu S, et al. Clinical efficacy of cardiac resynchronization therapy with an implantable defibrillator in a Japanese population: Results of the MIRACLE-ICD outcome measured in Japanese indication (MOMIJI) study. <i>Circ J<\/i> 2012; 76: 1911\u20131919.","DOI":"10.1253\/circj.CJ-11-1341"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Okamoto H, Hori M, Matsuzaki M, Tsutsui H, Yamazaki T, Nagai R, et al. Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study. <i>Int J Cardiol<\/i> 2013; 164: 238\u2013244.","DOI":"10.1016\/j.ijcard.2012.11.051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, et al. Exchange of beta-blockers in heart failure patients: Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial). <i>Eur J Heart Fail<\/i> 2005; 7: 640\u2013649.","DOI":"10.1016\/j.ejheart.2004.09.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, et al. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized crossover trial. <i>J Am Coll Cardiol<\/i> 2010; 55: 1780\u20131787.","DOI":"10.1016\/j.jacc.2010.01.024"},{"key":"10","unstructured":"10. Matsuzaki M, Ishii M, Izumi T, Ito H, Ito H, Ueda Y, et al. Guidelines for treatment of chronic heart failure (JCS 2010).http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2010_matsuzaki_h.pdf (accessed May 17, 2017)."}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/1\/82_CJ-17-0532\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T22:56:47Z","timestamp":1569970607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/1\/82_CJ-17-0532\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0532","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}